Edesa Biotech, Inc. (EDSA) stock
EDSANasdaqPharmaceutical PreparationsFiscal year ends September 30
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 5/30
$2.06+0.10 (+5.10%)
Close on Nov 18, 2026Market cap $19.86MP/E –Yield –
Edesa Biotech operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Edesa Biotech's operating cash flow for the twelve months ending Jun 30, 2026 was -$8.91M. For fiscal 2025 it was -$7.32M. The highest annual figure on record is -$2.80M in fiscal 2013.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | -$7.32M | – |
| FY2024 | Sep 30, 2024 | -$4.89M | – |
| FY2023 | Sep 30, 2023 | -$6.64M | – |
| FY2022 | Sep 30, 2022 | -$12.28M | – |
| FY2021 | Sep 30, 2021 | -$13.66M | – |
| FY2020 | Sep 30, 2020 | -$4.99M | – |
| FY2018 | Sep 30, 2018 | -$4.62M | – |
| FY2017 | Sep 30, 2017 | -$4.70M | – |
| FY2016 | Sep 30, 2016 | -$4.51M | – |
| FY2014 | Aug 31, 2014 | -$4.27M | – |
| FY2013 | Aug 31, 2013 | -$2.80M | – |
| FY2012 | Aug 31, 2012 | -$3.95M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | -$3.08M | – |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | -$2.02M | – |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | -$2.09M | – |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | -$1.72M | – |
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | -$1.70M | – |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | -$2.38M | – |
| Q1 FY2025CQ4 2024 | Dec 31, 2024 | -$1.52M | – |
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | -$967.04K | – |
| Q3 FY2024CQ2 2024 | Jun 30, 2024 | -$856.48K | – |
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | -$1.66M | – |
| Q1 FY2024CQ4 2023 | Dec 31, 2023 | -$1.41M | – |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | -$1.47M | – |
| Q3 FY2023CQ2 2023 | Jun 30, 2023 | -$1.81M | – |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | -$1.57M | – |
| Q1 FY2023CQ4 2022 | Dec 31, 2022 | -$1.79M | – |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | -$5.63M | – |
| Q3 FY2022CQ2 2022 | Jun 30, 2022 | -$3.03M | – |
| Q2 FY2022CQ1 2022 | Mar 31, 2022 | -$416.65K | – |
| Q1 FY2022CQ4 2021 | Dec 31, 2021 | -$3.21M | – |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | -$355.32K | – |
| Q3 FY2021CQ2 2021 | Jun 30, 2021 | -$3.12M | – |
| Q2 FY2021CQ1 2021 | Mar 31, 2021 | -$7.18M | – |
| Q1 FY2021CQ4 2020 | Dec 31, 2020 | -$3.01M | – |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | -$1.67M | – |
| Q3 FY2020CQ2 2020 | Jun 30, 2020 | -$1.35M | – |
| Q2 FY2020CQ1 2020 | Mar 31, 2020 | -$1.17M | – |
| Q1 FY2020CQ4 2019 | Dec 31, 2019 | -$789.71K | – |
| Q3 FY2019CQ2 2019 | Jun 30, 2019 | -$3.12M | – |
| Q2 FY2019CQ1 2019 | Mar 31, 2019 | -$398.88K | – |
| Q1 FY2019CQ4 2018 | Dec 31, 2018 | -$382.35K | – |
| Q4 FY2018CQ3 2018 | Sep 30, 2018 | -$971.23K | – |
| Q3 FY2018CQ2 2018 | Jun 30, 2018 | -$1.11M | – |
| Q2 FY2018CQ1 2018 | Mar 31, 2018 | -$1.39M | – |
| Q1 FY2018CQ4 2017 | Dec 31, 2017 | -$1.14M | – |
| Q4 FY2017CQ3 2017 | Sep 30, 2017 | -$1.12M | – |
| Q3 FY2017CQ2 2017 | Jun 30, 2017 | -$941.34K | – |
| Q2 FY2017CQ1 2017 | Mar 31, 2017 | -$1.28M | – |
| Q1 FY2017CQ4 2016 | Dec 31, 2016 | -$1.37M | – |
| Q4 FY2016CQ3 2016 | Sep 30, 2016 | -$1.19M | – |
See a number that looks wrong?